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Lung transplantation has evolved to an accepted treat-ment modality for patients suffering from end-stagelung disease. The number of listed patients waiting fora lung transplant is dramatically higher than the number
of available donor organs, which contributes to a 1-year mortality
on the waiting list of approximately 20% and of 40% after 2 years
of listing.1 Many strategies aiming for an increase of donor organs
have been discussed controversially and are partially under clinical
examination, such as the utilization of lungs from non–heart-
beating donors2 or the concept of living-related lung transplanta-
tion.3 Other approaches to the problem are even more experimen-
tal, such as pulmonary xenotransplantation. During the 2003
annual meeting, The International Society for Heart and Lung
Transplantation discussed the issue of redefining current lung
donor criteria and the concept of using marginal donor organs for
selected recipients in a main session. Many groups presented their
outcomes following lung transplantation using lungs from donors
who were heavy smokers,4 from donors with onset of fatal asth-
ma,5 or from elderly donors up to 77 years of age.6 One major
consensus of this intense discussion, however, was that some
donors are still considered as inadequate for lung donation, such as
patients who show signs of severe pneumonia or aspiration as well
as those who died from fulminant pulmonary embolism.
Here, we report on 3 cases in which lung grafts from patients
with fatal severe acute pulmonary embolism were successfully
transplanted. We further describe a novel strategy of in situ retro-
grade lung flush perfusion that we are routinely using in our
clinical program now, which is of special importance for lung graft
retrieval from donors with acute pulmonary embolism.
Clinical Summary
Between January 2001 and March 2003 lung grafts from 3 multi-
organ donors who died from hypoxia due to severe pulmonary
embolism were allocated by EuroTransplant and offered to our
program for transplantation.
The first donor was a 21-year-old female who developed sud-
den cardiac arrest immediately following 24 hours of air traveling
from Australia to Europe. Following 30 minutes of cardiopulmo-
nary resuscitation, she was admitted to an emergency hospital and
initial screening using computed tomography scanning revealed
the diagnosis of a large thrombus occluding approximately 90% of
the main pulmonary trunk as well as the left and right main
pulmonary artery with signs of right heart dilation. Hemodynamics
were stable under catecholamine support. Interestingly, arterial
blood gas analysis revealed adequate measures with a PaO2 of 376
mm Hg and a PaCO2 of 38.0 mm Hg at an FiO2 of 1.0. Bronchos-
copy showed normal findings with no signs of aspiration or mucus
accumulation. No intravenous lysis therapy was initiated. First
surgical inspection of the heart revealed severe right heart dilation.
The pulmonary artery pressure was not measured.
Donor number 2 was a 17-year-old obese female who also died
from hypoxia after cardiopulmonary resuscitation by an ambu-
lance team for sudden cardiac arrest. With signs of right heart
failure such as a prominent filling status of the jugular veins, in
combination with the obese body constitution, the ambulance
physician in charge suspected pulmonary embolism as the under-
lying initial event and administered intravenous lysis therapy be-
fore taking the patient to hospital. With mild catecholamine sup-
port at the time of arrival in the emergency hospital, cardiac
function was satisfying. At an FiO2 of 1.0 arterial blood gas
analysis showed a PaO2 of 544 mm Hg and a PaCO2 of 22.3 mm
Hg. First inspection of the right heart at the time of retrieval
showed no right heart dilation. Invasively measured pulmonary
artery pressure revealed normal parameters.
The third donor was a 26-year-old, also obese, female patient
and a heavy smoker who was on a diet for 7 days. She developed
sudden cardiac arrest while shopping. Following 20 minutes of
cardiopulmonary resuscitation she was admitted to an emergency
unit. Under mild catecholamine substitution she was hemodynam-
ically stable. Echocardiography revealed severe dilation of the
right atrium and ventricle, suggesting the diagnosis of acute pul-
monary embolism. Immediately, intravenous thrombolysis was
initiated. After 5 days in the intensive care unit, the patient was
diagnosed as brain-dead and she was allocated for multiorgan
donation. At the time of retrieval her arterial blood gas analysis
showed a PaO2 of 566 mm Hg at standard ventilation with an FiO2
of 1.0 and a positive end-expiratory pressure of 5 mm Hg. At first
surgical inspection her right ventricle and atrium showed normal
contraction patterns. Her systolic pulmonary artery pressure was
28 mm Hg.
Brain death was diagnosed in all 3 donors by 2 independent
neurologists following the general guidelines. All 3 recipients were
transplanted without cardiopulmonary bypass support. Recipient
data are depicted in Table 1. The first recipient’s health status was
dramatically deteriorated at the time of transplantation. She re-
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ceived a redo bilateral lung transplant for advanced end-stage graft
failure and required intensive care monitoring and treatment pre-
transplant. Following redo transplantation her grafts functioned
very well, with no signs of clinically relevant reperfusion injury.
She recovered rapidly and uneventfully and lived a satisfying life
at home until she developed Nocardia asteroides pneumonia fol-
lowed by treatment-refractory fatal sepsis.
The second patient developed mild pulmonary hypertension in
the early phase after transplantation and radiographically showed
signs of severe reperfusion edema in her transplanted right graft.
Therefore, she required extended nitric oxide–supplemented ven-
tilation. During that phase the compliance of her grafted lung was
very low compared with that of her native emphysema lung, which
required separated vantilation of her lungs with 2 different venti-
lators. Consequently, weaning from mechanical ventilation was
delayed. However, on postoperative day 8 she was taken off the
ventilator and recovered without experiencing further complica-
tions.
The third patient was extubated 10 hours after transplantation
and discharged from hospital on day 13 without any negative
event. Both recipients 2 and 3 are alive at home with no need for
oxygen administration.
Discussion
The imbalance between the number of patients listed for a lung
transplantation and the number of available donor organs has led to
extended waiting times after listing and, ultimately, to significant
mortality on the waiting list.1 Consequently, novel strategies to
increase the number of donor organs have been discussed and
partially introduced into the clinical setting. A first and very
important step was the idea of extending the currently accepted
criteria for donor selection. Many programs have begun to use
marginal or extended donors after reports suggesting equivalent
outcomes.
The Toronto group has previously published a first greater
retrospective review on 128 consecutive lung and heart-lung trans-
plants of which 51% were grafts retrieved from “extended do-
nors.”7 In that study by Pierre and coworkers,7 donors were
considered extended if any one of the following criteria were met:
age greater than 55 years, smoking history longer than 20 pack-
years, presence of chest radiographic film infiltrate, PaO2 of less
than 300 mm Hg, or purulent secretions on bronchoscopy. From
their study they have concluded that although many extended
donor lungs will result in acceptable postoperative function, cau-
tion needs to be exercised in the use of certain extended donor
lungs because there seems to be an increased early mortality rate
in that group of recipients. This particular finding underlines the
need for further studies to clearly identify the new borderline for
which donor lungs can be accepted for transplantation with a
reasonable chance for successful outcome and below which, on the
other hand, lungs should be rejected for transplantation. This study
further suggests different donor variables such as donor age, bron-
choscopic and radiograph findings, time of ventilation prior to
organ retrieval, and smoking history, which each can identify a
donor as an “extended” donor and which each could possibly be
extended to increase the number of transplantable donor organs.
Multiorgan donors who died from hypoxemia due to severe
pulmonary embolism, to our knowledge, have never been consid-
ered as lung donors in the literature, and further, they have not
been mentioned in the whole discussion on the extension of donor
criteria in lung transplantation. Since our successful transplanta-
tion of the lungs of donor number 1 (described above), who
developed severe pulmonary embolism after a long-distance flight,
into a patient who was listed for “high urgency” redo lung trans-
plantation for very advanced and life-threatening end-stage
chronic lung graft failure, we are now considering such donors as
potential lung donors. Especially for the evaluation of these donors
we have changed our strategy in that we routinely perform inva-
sive pulmonary artery pressure assessment prior to organ retrieval,
which we believe should not extend to a mild degree of pulmonary
hypertension. We further would not accept lungs from those do-
nors who show a PaO2 of less than 250 mm Hg with an adequate
ventilatory setup at an FiO2 of 1.0 and a positive end-expiratory
airway pressure of 5 mm Hg. Also, those donors should not extend
on other variables such as mild smoking history, older than 55
years of age, or aspiration, to name some.
If no further contraindication for the transplantation of these
organs exists, we routinely insert a left atrial pressure catheter into
the left atrium through the right upper pulmonary vein to measure
the preflush left atrial pressure. For lung flush preservation we use
8 L of a low-potassium dextran (Perfadex, Vitrolife, Go¨teborg,
Sweden) solution that is flushed through the lungs via the retro-
grade route. For that the left atrial auricle is cannulated and the
pulmonary artery is incised at the bifurcation of the left and right
main stem. While flushing the lungs the left atrial pressure is
continuously monitored and kept at the preflush level by adjusting
the height of the solution bag. This prevents, first, the disruption of
the smooth postcapillary pulmonary venous vessels by high flush
pressures and, second, a volume overload of the left ventricle when
the heart is also going to be transplanted. We are convinced that
the retrograde lung flush is very essential in donors with pulmo-
nary embolism, as in all 3 donors tremendous amounts of throm-
boembolic material were retrogradely flushed out of the vascula-
ture through the incision in the pulmonary artery.
TABLE 1. Recipient data
Donor
no.
Recipient
age (y) Gender Indication for LuTx
Post-LuTx
ventilation time
Post-LuTx
ICU stay Cause of death
1 46 Female Redo DLTx for chronic graft failure 5 days 6 days Severe Nocardia asteroides
Sepsis 6 months after Tx
2 58 Female Right SLTx for emphysema 8 days 12 days Alive, excellent graft function
3 46 Female DLTx for alpha1-ATD-emphysema 10 hours 1 day Alive, excellent graft function
LuTx, Lung transplant; ICU, intensive care unit; DLTx, bilateral LuTx; SLTx, single LuTx; ATD, antitrypsin deficiency.
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In conclusion, we are aware that lung donors who died from
hypoxemia due to severe pulmonary embolism are high-risk do-
nors and, thus, should be evaluated for transplantation very care-
fully. However, they should not be rejected as potential lung
donors just by the diagnosis because extended evaluation strategies
combined with the opportunity of retrograde flush perfusion might
help to ultimately retrieve well-functioning lung grafts, especially
for patients who have reached a disease state that may not allow
them to wait for the next organ offer. Because there are no reports
either on the use of lung grafts from donors with pulmonary
embolism nor on evaluation strategies or technical aspects in the
literature, we believe it was appropriate to report on our initial
experience.
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Isolated persistent fifth aortic arch with systemic-to-pulmonary arterial
connection
Mao-Sheng Hwang, MD,a,c Yu-Sheng Chang, MD,b,d Jaw-Ji Chu, MD,b,d and Wen-Jen Su, MD,a,c Taoyuan, Taiwan
Persistent fifth aortic arch (PFAA) is thought to be anextremely rare congenital heart disease (CHD). All pre-viously reported cases were associated with major car-diac anomalies and diagnosed coincidentally.1 More-
over, its presence was usually beneficial to the associated cardiac
anomalies. We report here a unique case of isolated PFAA (with-
out associated cardiac anomaly) with systemic-to-pulmonary arte-
rial connection, which caused severe congestive heart failure
(CHF) in a 2-month-old male infant.
Clinical Summary
A 2-month-old male infant weighing 3940 g was referred to our
hospital for evaluation of a suspected atypical huge patent ductus
arteriosus (PDA). He was the product of a 39-week gestation with
a birth weight of 3480 g. He presented with severe CHF and failure
to thrive. Chest radiographs revealed marked cardiomegaly, in-
creased pulmonary vascular markings, pulmonary edema, and a
convex pulmonary artery segment. The electrocardiogram demon-
strated biventricular hypertrophy. A repeat echocardiogram done
at our institution showed the segmental combination of solitus
normal heart {S,D,S} (S  visceroatrial situs solitus, D  D-
ventricular loop, S  conotruncus solitus); dilated left atrium, left
ventricle, and pulmonary arteries; normal left-sided aortic arch;
and preserved ventricular performance. From the parasternal short-
axis view, a continuous, turbulent flow was detected at the bifur-
cation of the pulmonary trunk, which was not typical for PDA
flow. From the modified suprasternal long-axis view, we detected
a huge vessel originating from the left anterior aspect of distal
ascending aorta (AsAo) but proximal to the transverse aortic arch
(Figure 1) and connecting to the superior margin of the bifurcation
of the pulmonary trunk. Isolated persistent fifth aortic arch with
systemic-to-pulmonary arterial connection was suspected. Con-
trast computed tomographic 3-dimensional reconstruction of the
heart and great vessels and ascending aortogram confirmed the
diagnosis. Hemodynamic data revealed large left-to-right shunt
(pulmonary/systemic blood flow ratio  4) and severe pulmonary
hypertension (pulmonary/systemic systolic blood pressure ratio 
1). The patient then underwent successful surgical ligation of this
abnormal vessel through median sternotomy.
Discussion
Persistent fifth aortic arch is thought to be an extremely rare CHD
because the fifth aortic arch almost always involutes during normal
From the Departments of Cardiologya and Cardiac Surgery,b Chang Gung
Children’s Hospital, and Departments of Pediatricsc and Surgery,d Chang
Gung University, Taoyuan, Taiwan.
Received for publication April 4, 2003; accepted for publication June 18,
2003.
Address for reprints: Wen-Jen Su, MD, Department of Cardiology, Chang
Gung Children’s Hospital, 5-7 Fu-Shin Street, Kweishan, Taoyuan 333,
Taiwan (E-mail: hwaien2003@yahoo.com.tw).
J Thorac Cardiovasc Surg 2003;126:1643-4
Copyright © 2003 by The American Association for Thoracic Surgery
0022-5223/2003 $30.00  0
doi:10.1016/S0022-5223(03)00954-1
Brief Communications
The Journal of Thoracic and Cardiovascular Surgery ● Volume 126, Number 5 1643
